Louisiana State Employees Retirement System Takes Position in The Cooper Companies, Inc. $COO

Louisiana State Employees Retirement System purchased a new position in The Cooper Companies, Inc. (NASDAQ:COOFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the medical device company’s stock, valued at approximately $715,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its holdings in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after purchasing an additional 73,165 shares during the period. Cresset Asset Management LLC bought a new position in Cooper Companies in the 2nd quarter worth $291,000. Cerity Partners LLC lifted its position in Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after purchasing an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its holdings in Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 973 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded up $0.32 during mid-day trading on Tuesday, reaching $72.93. The stock had a trading volume of 61,667 shares, compared to its average volume of 2,455,996. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The business’s 50 day moving average price is $64.66 and its 200 day moving average price is $73.26. The company has a market cap of $14.22 billion, a P/E ratio of 61.81, a price-to-earnings-growth ratio of 1.94 and a beta of 0.84.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Citigroup reissued a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. BNP Paribas Exane decreased their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, Mizuho set a $85.00 price target on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, Cooper Companies has an average rating of “Hold” and a consensus price target of $81.31.

View Our Latest Stock Analysis on COO

Cooper Companies Company Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

See Also

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.